Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda

Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda

BACKGROUND: Both 1 month of daily (1HP) and 3 months of weekly (3HP) isoniazid-rifapentine are recommended as short-course regimens for TB prevention among people living with HIV (PLHIV). We aimed to assess acceptability and preferences for 1HP vs. 3HP among PLHIV. METHODS: In a cross-sectional surv...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Musinguzi, H. E. Aschmann, J. L. Kadota, J. Nakimuli, F. Welishe, J. Kakeeto, C. Namale, L. Akello, A. Nakitende, C. Berger, A. Katamba, J. Tumuhamye, N. Kiwanuka, D. W. Dowdy, A. Cattamanchi, F. C. Semitala
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-02-01
Series:IJTLD Open
Subjects:
tuberculosis preventive treatment
acceptability
values
human immunodeficiency virus
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000002/art00005
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000002/art00005

Similar Items